Maniscalco, L.; Genovese, D.; Ravazzolo, B.; Vella, G.; Sparacia, B.; Vitale, F.; Matranga, D.; Amodio, E.
Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data. Vaccines 2023, 11, 1757.
https://doi.org/10.3390/vaccines11121757
AMA Style
Maniscalco L, Genovese D, Ravazzolo B, Vella G, Sparacia B, Vitale F, Matranga D, Amodio E.
Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data. Vaccines. 2023; 11(12):1757.
https://doi.org/10.3390/vaccines11121757
Chicago/Turabian Style
Maniscalco, Laura, Dario Genovese, Barbara Ravazzolo, Giuseppe Vella, Benedetta Sparacia, Francesco Vitale, Domenica Matranga, and Emanuele Amodio.
2023. "Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data" Vaccines 11, no. 12: 1757.
https://doi.org/10.3390/vaccines11121757
APA Style
Maniscalco, L., Genovese, D., Ravazzolo, B., Vella, G., Sparacia, B., Vitale, F., Matranga, D., & Amodio, E.
(2023). Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data. Vaccines, 11(12), 1757.
https://doi.org/10.3390/vaccines11121757
